Turn Therapeutics (TTRX) Current Leases (2024 - 2026)

Turn Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $47795.0 for Q1 2026.

• In Q1 2026, Current Leases changed N/A year-over-year to $47795.0; the TTM figure through Mar 2026 stood at $47795.0 (changed N/A YoY), while the FY2025 annual figure was $46295.0, up 13.86% from the prior year.
• Current Leases for Q1 2026 stood at $47795.0, up from $46295.0 in the prior quarter.
• The five-year high for Current Leases was $47795.0 in Q1 2026, with the low at $40660.0 in Q4 2024.
• The 3-year median for Current Leases is $45562.0 (2025), against an average of $44894.8.
• Peak annual rise in Current Leases reached 13.86% in 2025, while the deepest fall reached 13.86% in 2025.
• Turn Therapeutics' Current Leases stood at $40660.0 in 2024, then climbed by 13.86% to $46295.0 in 2025, then advanced by 3.24% to $47795.0 in 2026.
• Business Quant data shows TTRX's Current Leases at $47795.0 in Q1 2026, $46295.0 in Q4 2025, and $44829.0 in Q3 2025.